Download Breakout Session Overviews | Download Schedule of Breakout Sessions | View Conference Schedule
Given the potential to resolve a large number of unmet clinical indications, there has been an increase in the number of clinical studies using stem cell therapies derived from Induced pluripotent stem cells (iPSC). iPSC are a type of pluripotent stem cell that can be generated from adult somatic cells. This talk will focus on the current landscape, as well as the manufacturing and regulatory challenges that face clinical researchers when incorporating iPSCs into their cell therapies. 513
Presenter: Wing-Yee Cheung, PhD, Business Development Officer, STEMCELL Technologies Canada Inc.